The CSIC collaborates with Pharmaprocess, which will take place in Barcelona, from 29-30 October 2013. This global Forum will be focused on the pharmaceutical and biopharma industries. An expositive and ‘networking’ zone will allow visitors to learn first hand some of the current projects and technological offers.

An international project led by the Instituto de Biología Evolutiva (CSIC-UPF) has obtained the amoeba Capsaspora owczarzaki genome. The main striking result is that the unicellular ancestor of animals was very complex: it had more genes involved in multicellular functions than previously assumed and many of these genes play important roles in multicellulars organisms.

Scientists at the CSIC have developed a neuroprotective peptide which can be useful in the treatment and prevention of stroke or cerebral ischemia and other situations that cause brain damage. In vitro experiments have shown its efficacy when used on cultured neurons. Partners interested in licensing the patent are sought.

Two-layer dressings that facilitate the healing of wounds have been developed by CSIC scientists. The dressings are specially indicated for patients with low blood supply, with diabetes or elderly people. The product has been patented. Industrial partners are sought for license agreements or for keeping on with the research.

Scientists at the Instituto de Recursos Naturales y Agrobiologia de Salamanca (IRNASA) have obtained a method to detect the soft thick O.moubata. Also they are studying the tick saliva as a valuable source for drugs and vaccines.

Scientists at CSIC and at University of La Laguna have patented new compounds derived from tamoxifen, one of the most commonly used cancer-fighting drugs. The new molecules could be used as an alternative treatment to tamoxifen, as they don't have its adverse effects, and as diagnostic biomarkers due to their fluorescence quality. They could be used also as a laser pigment.

Scientists at CSIC and at the Imperial College London have synthesized a new peptide that promotes and inhibits inflammatory pattern in intestinal dendritic cells.

Un proyecto coordinado por el CSIC estudiará la modulación de receptores inmunológicos de la microglia para reducir la inflamación en el sistema nervioso central y para determinar su potencial neuroprotector y su utilidad como diana terapéutica.